Glutamate antagonists in therapy of stroke

Restorative Neurology and Neuroscience

Volumn 13, Issue 1-2, 1998, Pages 3-10

  Prass, Konstantin ^a   Dirnagl, Ulrich ^a,b  

^a HUMBOLDT UNIVERSITY   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Apoptosis; Cerebral ischemia; Clinical trials; Excitotoxicity; Inflammation; Neuroprotection

Indexed keywords

4 (3 PHOSPHONOALLYL) 2 PIPERAZINECARBOXYLIC ACID; 4 PHOSPHONOMETHYLPIPECOLIC ACID; 6 (1 IMIDAZOLYL) 7 NITRO 2,3 QUINOXALINEDIONE; 6,7 DICHLORO 5 NITRO 2,3 QUINOXALINEDIONE; AMPA RECEPTOR; APTIGANEL; CALCIUM ION; DECAHYDRO 6 [2 (1H TETRAZOL 5 YL)ETHYL] 3 ISOQUINOLINECARBOXYLIC ACID; DEXTRORPHAN; DNA; ELIPRODIL; GAVESTINEL; GLUTAMATE RECEPTOR ANTAGONIST; GLUTAMIC ACID; KAINIC ACID RECEPTOR; LANICEMINE; LUBELUZOLE; MAGNESIUM ION; METABOTROPIC RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; OXYGEN RADICAL; POTASSIUM ION; REMACEMIDE; SODIUM ION; TALAMPANEL; UNCLASSIFIED DRUG;

AMINO ACID TRANSPORT; APOPTOSIS; BRAIN ISCHEMIA; CALCIUM CELL LEVEL; CARDIOTOXICITY; CELL MEMBRANE DEPOLARIZATION; CLINICAL TRIAL; DNA DAMAGE; HALLUCINATION; HUMAN; INFLAMMATION; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; REVIEW; STROKE;

EID: 0031762340     PISSN: 09226028     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (65)

1. Albers, G.W. Potential therapeutic uses of N-methyl-D-aspartate antagonists in cerebral ischemia. Clin. Neuropharmacol. 13 (1990) 177-197.
2. Albin, R.L., Greenamyre, J.T. Alternative excitotoxic hypotheses. Neurology. 42 (1992) 733-738.
3. Arvin, B., Neville, L.F., Barone, F.C., Feuerstein, G.Z. The role of inflammation and cytokines in brain injury. Neurosci. Biobehav. Rev. 20 (1996) 445-452.
4. Baird, A.E., Warach, S.J. Magnetic resonance imaging of acute stroke. Cereb. Blood Flow Metab. 18 (1998) 583-609.
5. Baron, J.C., von Kummer, R., del Zoppo, G.J. Treatment of acute ischemic stroke. Challenging the concept of a rigid and universal time window. Stroke. 26 (1995) 2219-2221.
6. Becker, K.J. Inflammation and acute stroke. Curr. Opin. Neurol. 11 (1998) 45-49.
7. Benveniste, H. The excitotoxin hypothesis in relation to cerebral ischemia. Cerebrovasc Brain Metab. Rev. 3 (1991) 213-245.
8. Bruno, V., Battaglia, G., Copani, A., Giffard, R.G., Raciti, G., Raffaele, R., Shinozaki, H., Nicoletti, F. Activation of class II or III metabotropic glutamate receptors protects cultured cortical neurons against excitotoxic degeneration. Eur. J. Neurosci. 7 (1995) 1906-1913.
9. Buisson, A., Yu, S.P., Choi, D.W. DCG-IV selectively attenuates rapidly triggered NMDA-induced neurotoxicity in cortical neurons. Eur. J. Neurosci. 8 (1996) 138-143.
10. Chan, P.H. Role of oxidants in ischemic brain damage. Stroke. 27 (1996) 1124-1129.
11. Choi, D.W. Calcium-mediated neurotoxicity: relationship to specific channel types and role in ischemic damage. Trends Neurosci. 11 (1988) 465-469.
12. Choi, D.W. Glutamate neurotoxicity and diseases of the nervous system. Neuron. 1 (1988) 623-634.
13. Choi, D.W., Rothman, S.M. The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death. Annu. Rev. Neurosci. 13 (1990) 171-182.
14. Choi, D.W. Methods for antagonizing glutamate neurotoxicity. Cerebrovasc Brain Metab. Rev. 2 (1990) 105-147.
15. Choi, D.W. Excitotoxic cell death. J. Neurobiol. 23 (1992) 1261-1276.
16. Choi, D.W. Ischemia-induced neuronal apoptosis. Curr. Opin. Neurobiol. 6 (1996) 667-672.
17. Chopp, M., Li, Y. Apoptosis in focal cerebral ischemia. Acta Neurochir (Wien). 66 (1996) 21S-26S.
18. DeGraba, T.J., Ostrow, P., Hanson, S., Grotta, J.C. Motor performance, histologic damage, and calcium influx in rats treated with NBQX after focal ischemia. J. Cereb. Blood Flow Metab. 14 (1994) 262-268.
19. De Keyser, J., Van de Velde, V., Schellens, R.L., Hantson, L., Tritsmans, L., Gheuens, J., Van Peer, A., Woestenborghs, R., Franke, C.L., van Gorp, J. Safety and pharmacokinetics of the neuroprotective drug lubeluzole in patients with ischemic stroke. Clin. Ther. 19 (1997) 1340-1351.
20. Del Zoppo, G.J. Why do all drugs work in animals but none in stroke patients? 1. Drugs promoting cerebral blood flow. J. Intern. Med. 237 (1995) 79-88.
21. Del Zoppo, G.J., Wagner, S., Tagaya, M. Trends and future developments in the pharmacological treatment of acute ischaemic stroke. Drugs. 54 (1997) 9-38.
22. Fisher, M., Garcia, J.H. Evolving stroke and the ischemic penumbra. Neurology. 47 (1996) 884-888.
23. Gill, R., Nordholm, L., Lodge, D. The neuroprotective actions of 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline (NBQX) in a rat focal ischaemia model. Brain Res. 15, 580 (1992) 35-43.
24. Gotti, B., Benavides, J., MacKenzie, E.T., Scatton, B. The pharmacotherapy of focal cortical ischaemia in the mouse. Brain Res. 9, 522 (1990) 290-307.
25. Grotta, J., Clark, W., Coull, B., Pettigrew, L.C., Mackay, B., Goldstein, L.B., Meissner, I., Murphy, D., LaRue, L. Safety and tolerability of the glutamate antagonist CGS 19755 (Selfotel) in patients with acute ischemic stroke. Results of a phase IIa randomized trial. Stroke. 26 (1995) 602-605.
26. Grotta, J. Why do all drugs work in animals but none in stroke patients? 2. Neuroprotective therapy. J. Intern. Med. 237 (1995) 89-94.
27. Grotta, J. Lubeluzole treatment of acute ischemic stroke. The US and Canadian Lubeluzole Ischemic Stroke Study Group. Stroke. 28 (1997) 2338-2346.
28. 2+ permeability of KA-AMPA - gated glutamate receptor channels depends on subunit composition. Science. 10, 252 (1991) 851-853.
29. Hossmann, K.A. Periinfarct depolarizations. Cerebrovasc Brain Metab. Rev. 8 (1996) 195-208.
30. Iadecola, C. Bright and dark sides of nitric oxide in ischemic brain injury. Trends Neurosci. 20 (1997) 132-139.
31. Ikonomidou, C., Turski, L. Excitotoxicity and neurodegenerative diseases. Cure Opin. Neurol. 8 (1995) 487-497.
32. Ishida, M., Saitoh, T., Tsuji, K., Nakamura, Y., Kataoka, K., Shinozaki, H. Novel agonists for metabotropic glutamate receptors: trans- and cis-2-(2-carboxy-3-methoxymethylcyclopropyl)glycine (trans- and cis-MCG-I). Neuropharmacology. 34 (1995) 821-827.
33. Kochanek, P.M., Hallenbeck, J.M. Polymorphonuclear leukocytes and monocytes/macrophages in the pathogenesis of cerebralischemia and stroke. Stroke. 23 (1992) 1367-1379.
34. Kristian, T., Siesjo, B.K. Calcium in ischemic cell death. Stroke. 29 (1998) 705-718.
35. Laurie, D.J., Seeburg, P.H. Ligand affinities at recombinant N-methyl-D-aspartate receptors depend on subunit composition. Eur. J. Pharmacol. 268 (1994) 335-345.
36. Lauritzen, M. Pathophysiology of the migraine aura. The spreading depression theory. Brain. 117 (1994) 199-210.
37. Lees, K.R. Cerestat and other NMDA antagonists in ischemic stroke. Neurology. 49 (1997) S66-S69.
38. Lodder, J. Lubeluzole treatment of acute ischemic stroke. Stroke. 29 (1998) 1067.
39. MacManus, J.P., Linnik, M.D. Gene expression induced by cerebral ischemia: an apoptotic perspective. J. Cereb. Blood Flow Metab. 17 (1997) 815-832.
40. McCulloch, J. Ischaemic brain damage-prevention with competitive and non-competitive antagonists of N-methyl-D-aspartate receptors. Drug Res. 41 (1991) 319-324.
41. Meldrum, B. Protection against ischemic brain damage by excittatory amino acid antagonists; in Bazan NG, Braquet P, Ginsberg MD (eds): Neurochemical Correlates of Cerebral Ischemia. New York, Plenum Press, (1992) pp 245-263.
42. Meldrum, B.S. Cytoprotective therapies in stroke. Curr. Opin. Neurol. 8 (1995) 15-23.
43. Mohr, J.P., Mast, H., Thompson, J.L., Sacco, R.L. Are more complex study designs needed for future acute stroke trials? Cerebrovasc Dis. 81 (1998) 17-22.
44. Muir, K.W., Lees, K.R. Clinical experience with excitatory amino acid antagonist drugs. Stroke. 26 (1995) 503-513.
45. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N. Engl. J. Med. 333 (1995) 1581-1587.
46. Obrenovitch, T.P., Richards, D.A. Extracellular neurotransmitter changes in cerebral ischaemia. Cerebrovasc Brain Metab. Rev. 7 (1995) 1-54.
47. Obrenovitch, T.P. The ischaemic penumbra: twenty years on. Cerebrovasc Brain Metab. Rev. 7 (1995) 297-323.
48. Olney, J.W. Brain lesion, obesity and other disturbances in mice treated with moonosodium glutamate. Science 164 (1969) 719-721.
49. Pellegrini-Giampietro, D.E., Zukin, R.S., Bennett, M.V., Cho. S., Pulsinelli, W.A. Switch in glutamate receptor subunit gene expression in CA1 subfield of hippocampus following global ischemia in rats. Proc. Natl. Acad. Sci. USA. 89 (1992) 10499-10503.
50. Pin, J.P., Duvoisin, R. The metabotropic glutamate receptors: structure and functions. Neuropharmacology. 34 (1995) 1-26.
51. Pulsinelli, W. Pathophysiology of acute ischaemic stroke. Lancet. 339 (1992) 533-536.
52. Pulsinelli, W., Dirnagl, U., Jacewicz, M., Buchan, A. Antagonists of excitatory amino acid neurotransmitters: A comparison of their effects on global versus focal ischemia. Drug research related to neuroactive amino acids, Alfred Benzon Symposium 32, (1992) 225-238.
53. Savitz, S.I., Rosenbaum, D.M. Apoptosis in neurological disease. Neurosurgery. 42 (1998) 555-572.
54. Scatton, B., Carter, C., Benavides, J., Giroux, C. Cerebrovascular Disease. 1 (1991) 121-135.
55. Scatton, B. Excitatory amino acid receptor antagonists: a novel treatment for ischemic cerebrovascular diseases. Life Sci. 55 (1994) 2115-2124.
56. Sereghy, T., Overgaard, K., Boysen, G. Neuroprotection by excitatory amino acid antagonist augments the benefit of thrombolysis in embolic stroke in rats. Stroke. 24 (1993) 1702-1708.
57. Siesjo, B.K., Katsura, K., Kristian, T. The biochemical basis of cerebral ischemic damage. J. Neurosurg. Anesthesiol. 7 (1995) 47-52.
58. Siesjo, B.K., Katsura, K., Zhao, Q., Folbergrova, J., Pahlmark, K., Siesjo, P., Smith, M.L. Mechanisms of secondary brain damage in global and focal ischemia: a speculative synthesis. J. Neurotrauma. 12 (1995) 943-956.
59. Shuaib, A., Kanthan, R . Amplification of inhibitory mechanisms in cerebral ischemia: an alternative approach to neuronal protection. Histol. Histopathol. 12 (1997) 185-194.
60. Stern-Bach, Y., Bettler, B., Hartley, M., Sheppard, P.O., O'Hara, P.J., Heinemann, S.F. Agonist selectivity of glutamate receptors is specified by two domains structurally related to bacterial amino acid-binding proteins. Neuron. 13 (1994) 1345-1357.
61. Traystman, R.J., Kirsch, J.R., Koehler, R.C. Oxygen radical mechanisms of brain injury following ischemia and reperfusion. J. Appl. Physiol. 71 (1991) 1185-1195.
62. Turski, L. The N-methyl-D-aspartate receptor complex. Various sites of regulation and clinical consequences. Drug Res. 40 (1990) 511-514.
63. Watkins, J.C., Evans, R.H. Excitatory amino acid transmitters. Annu. Rev. Pharmacol. Toxicol 21 (1981) 165-204.
64. Yu, S.P., Sensi, S.L., Canzoniero, L.M., Buisson, A., Choi, D.W. Membrane-delimited modulation of NMDA currents by metabotropic glutamate receptor subtypes 1/5 in cultured mouse cortical neurons. J. Physiol. (Lond). 15, 499 (1997) 721-732.
65. Zivin, J.A. Factors determining the therapeutic window for stroke. Neurology. 50 (1998) 599-603.